CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 63.66 CNY 1.3% Market Closed
Market Cap: 10.3B CNY

Operating Margin
CanSino Biologics Inc

-19.1%
Current
-201%
Average
6.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-19.1%
=
Operating Profit
-185.2m
/
Revenue
971.8m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
CN
CanSino Biologics Inc
SSE:688185
10.3B CNY
-19%
US
Eli Lilly and Co
NYSE:LLY
996.4B USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
503.4B USD
27%
CH
Roche Holding AG
SIX:ROG
252.6B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
211.6B GBP
24%
CH
Novartis AG
SIX:NOVN
207.5B CHF
33%
US
Merck & Co Inc
NYSE:MRK
244.9B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
42%
IE
Endo International PLC
LSE:0Y5F
209B USD
11%
US
Pfizer Inc
NYSE:PFE
143.2B USD
29%
No Stocks Found

CanSino Biologics Inc
Glance View

Market Cap
10.3B CNY
Industry
Pharmaceuticals

CanSino Biologics Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Tianjin, Tianjin and currently employs 1,946 full-time employees. The company went IPO on 2019-03-28. CanSino Biologics Inc is a clinical-stage vaccine company in China. The firm's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

Intrinsic Value
53.43 CNY
Overvaluation 16%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-19.1%
=
Operating Profit
-185.2m
/
Revenue
971.8m
What is the Operating Margin of CanSino Biologics Inc?

Based on CanSino Biologics Inc's most recent financial statements, the company has Operating Margin of -19.1%.

Back to Top